Apollo Hospitals Partners with Ainnova Tech to Enhance AI-Driven Disease Detection

These AI-driven solutions are designed to improve early detection of diseases such as liver fibrosis, cardiovascular and chronic kidney diseases, type 2 diabetes, and lung abnormalities.

Apollo Hospitals has partnered strategically with Ainnova Tech, a healthcare technology company, to integrate AI into disease detection and prediction.

This partnership will enable Apollo to leverage Ainnova's advanced AI algorithms to enhance the early and accurate diagnosis of complex health conditions.

As part of the deal, Ainnova has secured an exclusive license for AI algorithms validated with over 2.3 million data points to power its Vision AI platform.

These AI-driven solutions are designed to improve early detection of diseases such as liver fibrosis, cardiovascular and chronic kidney diseases, type 2 diabetes, and lung abnormalities.

The collaboration follows a recent joint venture between Avant Technologies and Ainnova to create Ai-Nova Acquisition (AAC), which holds the global license to develop and market Ainnova's technology.

Apollo's involvement strengthens this venture's global outreach, with the first commercial pilot programs set to launch in the Americas.

Strategic Expansion in Brazil

With a population exceeding 200 million, Brazil has already secured regulatory approval from the country's health authority, ANVISA, paving the way for a wider rollout of these AI-based solutions.

The Vision AI platform is expected to significantly improve chronic disease management by offering comprehensive preventive health assessments.

The system will facilitate early referrals from primary care or community health services to specialist care, enhancing overall patient outcomes.

Apollo and Ainnova plan to expand the scope of AI-driven healthcare solutions, with new innovations expected to be introduced soon.

Earlier this month, Apollo also signed a term sheet with Ion Beam Applications (IBA) for the procurement of a ProteusONE compact proton therapy solution, further reinforcing its commitment to advanced healthcare technologies.

Stay tuned for more such updates on Digital Health News.